Manufacturing USA: 106K Trained, 2,900 Members
Manufacturing USA 2023 Annual Report
1920 organizations
Headline outcome
Challenge
The United States faced declining competitiveness in advanced manufacturing as the gap between laboratory research and commercial production—the "valley of death"—prevented promising technologies from reaching scale. Small and medium manufacturers, representing 61% of Manufacturing USA members, lacked access to expensive advanced manufacturing equipment, technical expertise, and R&D capabilities needed to adopt emerging technologies like additive manufacturing, advanced materials, and digital manufacturing systems. Without coordinated national infrastructure for pre-competitive technology development, the US risked losing manufacturing jobs and capabilities to international competitors while struggling to translate federal research investments into commercial manufacturing applications. Additionally, a severe shortage of workers skilled in advanced manufacturing technologies threatened long-term competitiveness.
Solution
Congress authorized Manufacturing USA in 2014, and federal agencies established 17 institutes between 2014-2023, each focused on a specific technology domain. The institutes operate as public-private partnerships, receiving federal funding matched by state and private sector investments. Each institute provides shared access to advanced manufacturing equipment, conducts collaborative applied R&D projects involving multiple member organizations, and delivers workforce education programs. The Department of Defense established institutes including America Makes (additive manufacturing) and BioMADE (bioindustrial manufacturing), Commerce launched NIIMBL (biopharmaceuticals), and DOE created institutes focused on energy-related manufacturing technologies. By fiscal year 2023, the program had matured with all 17 institutes operational across the country, conducting over 560 major applied R&D projects annually and engaging nearly 2,000 member organizations.
Outcomes
By fiscal year 2023, Manufacturing USA had grown to 1,920 member organizations (nearly 50% increase since 2017, more than double 2016 levels), with 61% being manufacturing firms and 69% of industry members being small and medium manufacturers critical to US supply chains. The institutes conducted over 560 major applied research and development collaboration projects. The number of people participating in institute and partner-led advanced manufacturing education and workforce programs increased 25% over the prior year to 106,000 workers, students, and educators engaged in 2023, reflecting an 80% increase in post-secondary teachers trained. Individual institute successes included BioMADE growing from $18 million annual revenue in FY2021 to $378 million in FY2023 with 67 active projects and 240 members. The network received $416 million in funding in fiscal year 2022, with substantial private sector cost-sharing and leverage. Seven institutes grew their memberships by 50% or more between FY2019-2023.
Expert Insights
Manufacturing USA demonstrates that coordinated federal investment in manufacturing innovation infrastructure can effectively bridge the valley of death between research and production when structured as public-private partnerships with shared facilities and collaborative R&D. The program's success in attracting and retaining SME membership (69% of industry members) validates the hub-and-spoke model where smaller firms gain access to capabilities they could never afford individually. The 80% year-over-year increase in post-secondary teachers trained suggests the program is creating a multiplier effect in workforce development beyond direct training. However, GAO reviews note ongoing challenges in establishing consistent performance metrics across the multi-agency network and ensuring long-term sustainability as federal funding phases out. The rapid revenue growth of newer institutes like BioMADE indicates that well-structured institutes can achieve financial sustainability relatively quickly in high-value sectors.
Discussion
Sign in to share your thoughts on this case.
No comments yet. Be the first to contribute.